Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Jessica Cardenas

Concepts (234)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Venous Thromboembolism
11
2024
332
4.680
Why?
Wounds and Injuries
29
2026
959
4.560
Why?
Thrombosis
12
2026
398
3.930
Why?
Hemostasis
15
2026
100
3.860
Why?
Shock, Hemorrhagic
10
2026
195
3.490
Why?
Blood Coagulation Disorders
12
2025
190
3.160
Why?
Thrombin
16
2026
175
2.190
Why?
Endothelial Cells
9
2026
876
2.180
Why?
Hemorrhage
9
2026
825
1.660
Why?
Fibrinolysis
8
2026
162
1.630
Why?
Thrombophilia
4
2022
89
1.480
Why?
Thrombelastography
18
2026
182
1.440
Why?
Enoxaparin
3
2022
68
1.420
Why?
Endothelium, Vascular
8
2026
952
1.420
Why?
Blood Platelets
8
2026
382
1.350
Why?
Blood Transfusion
9
2026
394
1.350
Why?
Antithrombins
4
2025
71
1.340
Why?
Syndecan-1
6
2023
42
1.230
Why?
Blood Coagulation
12
2025
267
1.130
Why?
Blood Component Transfusion
7
2026
99
1.050
Why?
Fibrinogen
6
2026
182
0.970
Why?
Antithrombin III
3
2022
18
0.960
Why?
Plasma
3
2026
222
0.950
Why?
Extracellular Vesicles
3
2026
176
0.930
Why?
von Willebrand Factor
2
2025
84
0.800
Why?
Cadherins
2
2023
202
0.720
Why?
Platelet Transfusion
2
2019
76
0.660
Why?
Shock
2
2021
101
0.650
Why?
alpha-2-Antiplasmin
3
2026
4
0.630
Why?
Inflammation
7
2026
2919
0.620
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
1
2024
449
0.610
Why?
Rats, Sprague-Dawley
7
2026
2537
0.590
Why?
Plasminogen Activator Inhibitor 1
3
2019
83
0.580
Why?
Brain Injuries, Traumatic
6
2025
466
0.570
Why?
Humans
69
2026
146342
0.560
Why?
Periodicals as Topic
1
2021
214
0.560
Why?
Anticoagulants
5
2023
746
0.510
Why?
Cell-Derived Microparticles
2
2015
73
0.500
Why?
Prospective Studies
17
2025
8123
0.480
Why?
Injury Severity Score
10
2025
572
0.480
Why?
Fibrinolysin
2
2026
20
0.470
Why?
Rats
6
2026
5586
0.460
Why?
Male
42
2026
73396
0.460
Why?
Capillary Permeability
3
2023
133
0.440
Why?
Tissue Plasminogen Activator
3
2026
245
0.440
Why?
Endothelial Progenitor Cells
1
2015
19
0.430
Why?
Adult
33
2026
41087
0.410
Why?
Middle Aged
31
2026
36619
0.390
Why?
Hemostatics
2
2023
66
0.350
Why?
Inflammation Mediators
2
2025
508
0.340
Why?
Obesity, Morbid
1
2015
287
0.320
Why?
Animals
14
2026
38107
0.320
Why?
Thrombomodulin
4
2025
15
0.320
Why?
Arthroplasty, Replacement, Knee
1
2015
385
0.300
Why?
Resuscitation
5
2026
314
0.290
Why?
Glycocalyx
3
2019
30
0.280
Why?
Female
34
2026
79499
0.270
Why?
Blood Coagulation Tests
5
2025
72
0.260
Why?
Fibrin
3
2023
84
0.250
Why?
Risk Factors
8
2025
10921
0.250
Why?
Postoperative Complications
2
2023
3034
0.250
Why?
Factor VIII
2
2026
107
0.250
Why?
Radiobiology
1
2026
7
0.240
Why?
Blood Preservation
2
2021
346
0.240
Why?
Cohort Studies
5
2022
6077
0.240
Why?
Endothelium
2
2023
119
0.230
Why?
Radiation Oncology
1
2026
83
0.220
Why?
Fibrin Fibrinogen Degradation Products
2
2023
92
0.220
Why?
Interleukin-8
2
2023
268
0.220
Why?
Interleukin-6
3
2025
784
0.210
Why?
Retrospective Studies
7
2024
17438
0.210
Why?
Oxidative Stress
2
2025
1369
0.210
Why?
ABO Blood-Group System
1
2025
56
0.210
Why?
Blood Donors
1
2026
145
0.210
Why?
Platelet Function Tests
6
2022
37
0.200
Why?
Mice, Inbred C57BL
3
2026
6034
0.200
Why?
Coagulants
1
2023
20
0.200
Why?
Endothelial Protein C Receptor
1
2023
6
0.200
Why?
Sulfates
1
2023
45
0.190
Why?
Platelet Aggregation
5
2022
99
0.180
Why?
Chemokines
1
2023
217
0.180
Why?
Chemoprevention
1
2023
91
0.180
Why?
Biomarkers
10
2026
4340
0.180
Why?
Sarcoidosis, Pulmonary
1
2023
100
0.170
Why?
Venous Thrombosis
1
2023
199
0.170
Why?
Lung Injury
1
2025
263
0.170
Why?
Pulmonary Embolism
1
2023
246
0.160
Why?
Infusion Pumps
1
2020
33
0.160
Why?
Sarcoidosis
1
2023
164
0.160
Why?
Endovascular Procedures
1
2025
390
0.150
Why?
Mice
5
2026
18297
0.150
Why?
Interferon-gamma
1
2023
781
0.150
Why?
Publishing
1
2021
117
0.150
Why?
Time Factors
5
2025
7109
0.150
Why?
Catecholamines
2
2017
88
0.150
Why?
Neutrophil Infiltration
1
2020
107
0.150
Why?
Cells, Cultured
2
2025
4118
0.150
Why?
Liver
2
2026
1864
0.150
Why?
Disease Models, Animal
5
2026
4580
0.150
Why?
Carcinoma, Pancreatic Ductal
1
2023
297
0.140
Why?
Multiple Trauma
1
2020
118
0.140
Why?
Platelet Aggregation Inhibitors
1
2022
499
0.140
Why?
Peripheral Arterial Disease
1
2025
507
0.140
Why?
Mitochondria
1
2025
997
0.140
Why?
Cytokines
1
2025
2081
0.130
Why?
Serum Albumin
1
2018
147
0.130
Why?
E-Selectin
1
2017
61
0.120
Why?
Incidence
1
2024
2936
0.120
Why?
Blood Coagulation Factors
3
2026
71
0.120
Why?
Electric Injuries
1
2016
2
0.120
Why?
Intracranial Hemorrhages
1
2017
106
0.120
Why?
Aged
8
2026
26432
0.120
Why?
Adrenal Glands
1
2017
77
0.120
Why?
Burns, Electric
1
2016
25
0.120
Why?
Disease-Free Survival
1
2018
778
0.120
Why?
RNA
1
2023
926
0.120
Why?
Transcriptome
1
2023
1068
0.120
Why?
Predictive Value of Tests
4
2026
2113
0.120
Why?
Sympathetic Nervous System
1
2017
177
0.110
Why?
Energy Drinks
1
2015
3
0.110
Why?
Platelet Count
3
2021
95
0.110
Why?
Dietary Supplements
1
2020
587
0.110
Why?
Apoptosis
2
2025
2439
0.110
Why?
Tumor Necrosis Factor-alpha
1
2020
1224
0.110
Why?
Cysteine-Rich Protein 61
1
2014
6
0.110
Why?
Fluid Therapy
1
2016
154
0.110
Why?
Vascular Diseases
1
2017
252
0.100
Why?
Lung
2
2025
4122
0.100
Why?
Blood Specimen Collection
1
2014
37
0.100
Why?
Pancreatic Neoplasms
1
2023
944
0.100
Why?
Cell Line
1
2020
2814
0.100
Why?
Protein C
1
2014
54
0.100
Why?
Emergency Medical Services
1
2021
680
0.100
Why?
Wounds, Nonpenetrating
1
2017
305
0.100
Why?
Hemostatic Techniques
1
2014
50
0.100
Why?
Survival Rate
1
2018
2092
0.100
Why?
Texas
1
2014
280
0.100
Why?
Case-Control Studies
3
2016
3647
0.090
Why?
Insulin-Like Growth Factor I
1
2014
320
0.090
Why?
Homeostasis
1
2016
646
0.090
Why?
Enzyme-Linked Immunosorbent Assay
3
2018
846
0.080
Why?
Oxidation-Reduction
1
2014
1075
0.080
Why?
ROC Curve
2
2026
617
0.080
Why?
Neoplasms
1
2026
2954
0.080
Why?
Severity of Illness Index
2
2015
2921
0.070
Why?
Prognosis
4
2019
4351
0.070
Why?
Young Adult
7
2019
14330
0.070
Why?
Trauma Severity Indices
2
2018
115
0.060
Why?
Cell Proliferation
1
2014
2502
0.060
Why?
Color
1
2026
80
0.060
Why?
Cell Adhesion Molecules
1
2025
180
0.050
Why?
Trauma Centers
2
2017
441
0.050
Why?
Calcium-Binding Proteins
1
2025
221
0.050
Why?
Cell Adhesion
1
2025
447
0.050
Why?
Heparin, Low-Molecular-Weight
1
2023
37
0.050
Why?
Longitudinal Studies
2
2026
3017
0.050
Why?
Aged, 80 and over
3
2025
8391
0.050
Why?
Pilot Projects
2
2022
1888
0.050
Why?
Multivariate Analysis
2
2017
1543
0.050
Why?
Medical Futility
1
2023
32
0.050
Why?
Biology
1
2023
90
0.050
Why?
Reference Standards
1
2023
176
0.050
Why?
Heparin
1
2023
247
0.040
Why?
Reactive Oxygen Species
1
2025
610
0.040
Why?
Vital Capacity
1
2023
293
0.040
Why?
Cell Separation
1
2023
300
0.040
Why?
Immunomodulation
1
2023
98
0.040
Why?
Breast Neoplasms
1
2014
2418
0.040
Why?
Immunization, Passive
1
2021
90
0.040
Why?
Logistic Models
2
2017
2126
0.040
Why?
Genomics
1
2026
853
0.040
Why?
Leukocyte Reduction Procedures
1
2020
29
0.040
Why?
B7-H1 Antigen
1
2023
245
0.040
Why?
Metabolomics
1
2026
738
0.040
Why?
Chemokine CCL2
1
2020
112
0.040
Why?
Intensive Care Units
1
2026
925
0.040
Why?
Flow Cytometry
1
2023
1163
0.040
Why?
Cold Temperature
1
2020
208
0.040
Why?
Proteomics
1
2026
1203
0.040
Why?
In Vitro Techniques
1
2020
1041
0.040
Why?
Tumor Microenvironment
1
2023
747
0.030
Why?
Mice, Knockout
1
2025
3125
0.030
Why?
Urokinase-Type Plasminogen Activator
1
2017
25
0.030
Why?
Multicenter Studies as Topic
1
2019
417
0.030
Why?
Edema
1
2018
131
0.030
Why?
Treatment Outcome
2
2025
11821
0.030
Why?
Neutrophils
1
2023
1133
0.030
Why?
Platelet Adhesiveness
1
2016
14
0.030
Why?
Antifibrinolytic Agents
1
2017
68
0.030
Why?
Models, Theoretical
1
2020
561
0.030
Why?
Epinephrine
1
2017
160
0.030
Why?
Norepinephrine
1
2017
201
0.030
Why?
Kaolin
1
2015
7
0.030
Why?
Risk Assessment
1
2025
3712
0.030
Why?
Methionine
1
2016
160
0.030
Why?
Arachidonic Acid
1
2015
101
0.030
Why?
Fibrin Clot Lysis Time
1
2014
10
0.030
Why?
Linear Models
1
2017
857
0.030
Why?
Healthy Volunteers
1
2015
218
0.030
Why?
Punctures
1
2014
40
0.030
Why?
Partial Thromboplastin Time
1
2014
53
0.030
Why?
Random Allocation
1
2015
366
0.030
Why?
Thromboplastin
1
2014
67
0.030
Why?
3T3 Cells
1
2014
152
0.030
Why?
Forkhead Box Protein O1
1
2014
36
0.030
Why?
MCF-7 Cells
1
2014
133
0.030
Why?
Clinical Trials as Topic
1
2019
1064
0.030
Why?
Survival Analysis
1
2017
1378
0.020
Why?
Solubility
1
2014
240
0.020
Why?
Early Diagnosis
1
2014
251
0.020
Why?
Proportional Hazards Models
1
2017
1331
0.020
Why?
Forkhead Transcription Factors
1
2014
209
0.020
Why?
Femoral Artery
1
2014
183
0.020
Why?
Forecasting
1
2014
388
0.020
Why?
Reference Values
1
2014
796
0.020
Why?
Adolescent
3
2017
22557
0.020
Why?
Randomized Controlled Trials as Topic
1
2019
1763
0.020
Why?
MAP Kinase Signaling System
1
2014
307
0.020
Why?
Sensitivity and Specificity
1
2017
1998
0.020
Why?
Hospitalization
1
2023
2475
0.020
Why?
Hospital Mortality
1
2017
1051
0.020
Why?
Burns
1
2016
365
0.020
Why?
Cardiac Catheterization
1
2014
571
0.020
Why?
Cell Movement
1
2014
951
0.020
Why?
Pregnancy
1
2022
7230
0.020
Why?
Models, Biological
1
2016
1761
0.020
Why?
Prevalence
1
2015
2861
0.020
Why?
Reproducibility of Results
1
2014
3416
0.010
Why?
Phenotype
1
2014
3206
0.010
Why?
Infant, Newborn
1
2015
6460
0.010
Why?
Infant
1
2015
10114
0.010
Why?
Child, Preschool
1
2015
11913
0.010
Why?
United States
1
2014
16136
0.010
Why?
Child
1
2015
22693
0.010
Why?
Cardenas's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)